Alliqua BioMedical Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
1,797.70
4,786.10
12,177.00
16,294.00
19,565.00
Cost of Goods Sold (COGS) incl. D&A
2,102.30
3,764.30
7,373.00
9,105.00
11,167.00
Gross Income
304.60
1,021.80
4,804.00
7,189.00
8,398.00
SG&A Expense
11,727.90
25,661.60
32,909.00
33,130.00
23,807.00
EBIT
12,032.50
24,639.80
-
-
16,229.00
Unusual Expense
9,933.50
822.00
693.00
5,886.00
10,295.00
Non Operating Income/Expense
4.80
0.40
-
142.00
206.00
Interest Expense
-
-
1,565.00
2,541.00
2,282.00
Pretax Income
21,967.90
25,431.40
28,935.00
33,754.00
28,600.00
Income Tax
9.00
14.00
1,718.00
715.00
743.00
Consolidated Net Income
21,976.90
25,445.40
27,217.00
33,039.00
27,857.00
Net Income
21,976.90
25,445.40
27,217.00
33,039.00
27,857.00
Net Income After Extraordinaries
21,976.90
25,445.40
28,417.00
37,835.00
30,007.00
Net Income Available to Common
22,438.90
25,445.40
26,017.00
28,243.00
25,707.00
EPS (Basic)
31.40
17.40
11.30
100.99
5.99
Basic Shares Outstanding
714.10
1,462.90
2,306.20
279.70
4,291.60
EPS (Diluted)
31.42
17.39
11.28
100.99
5.99
Diluted Shares Outstanding
714.10
1,462.90
2,306.20
279.70
4,291.60
EBITDA
11,358.30
23,559.50
25,315.00
24,201.00
10,984.00
Other Operating Expense
-
-
-
2,093.00
820.00
Non-Operating Interest Income
2.90
30.70
42.00
-
-
Preferred Dividends
462.00
-
-
-
-
About Alliqua BioMedical
View Profile
